Market Overview
Knee replacement surgery, also known as total knee arthroplasty (TKA), involves resurfacing a damaged knee joint with metal and plastic components to relieve pain and restore function. The global market has experienced sustained expansion, with total joint replacement broadly valued at approximately $22.5 billion in 2024 and projected to reach nearly $28.7 billion by 2030 at a 4% compound annual growth rate. Knee replacements represent a substantial and growing share of this sector, driven by their status as one of the most frequently performed orthopedic procedures worldwide.
- •Procedural volumes are rising steadily, with projections indicating a roughly 24% increase in primary total knee arthroplasties every five years in Medicare populations beyond 2020
- •The market's expansion reflects both an aging global population and increasing prevalence of obesity-related knee osteoarthritis
- •Implant longevity and surgical technique improvements have broadened eligibility criteria, extending procedures to younger, more active patients
Growth Drivers
The dominant force propelling market expansion is the rising global burden of knee osteoarthritis, a degenerative joint disease linked to aging demographics and increasing body mass index trends worldwide. Healthcare systems in developed and emerging economies are investing in orthopedic infrastructure and expanding insurance coverage for joint replacement procedures. Concurrently, minimally invasive surgical approaches and advanced biomaterials are reducing recovery times and complication rates, further stimulating demand.
- •Global disability trends in knee osteoarthritis continue to rise, with projections indicating substantial increases in knee-related healthcare burdens through 2050 based on Global Burden of Disease data
- •Younger patient cohorts are increasingly electing knee replacement surgery, supported by improved implant durability and desire to maintain active lifestyles
- •Healthcare policy shifts toward value-based care are encouraging adoption of cost-effective, outcome-driven implant technologies
Segmentation and Regional Analysis
Geographically, North America commands the largest market share, driven by high healthcare expenditure, favorable reimbursement frameworks, and well-established orthopedic surgical infrastructure. Europe represents a mature but steadily growing market, while the Asia-Pacific region is emerging as a high-growth area fueled by expanding healthcare access, rising disposable incomes, and aging populations in China, India, and Japan. Latin America and the Middle East are also showing increasing adoption as surgical expertise and hospital infrastructure improve.
- •The United States accounts for a significant portion of global procedure volumes, with demand further amplified by expanding indications to patients under 65
- •Asia-Pacific markets are accelerating due to rapid urbanization, growing middle-class populations, and improving access to elective orthopedic procedures
- •Europe's market benefits from comprehensive public health systems and strong patient advocacy networks driving early intervention and treatment access
Trends and Outlook
What are the recent trends and outlook?
The market is undergoing a significant technological transformation driven by the rapid adoption of robotic-assisted surgery and artificial intelligence-enabled surgical planning tools. The American Academy of Orthopaedic Surgeons anticipates that 50% of total knee arthroplasties will be performed using robotic assistance by 2030, as the technology improves implant alignment precision and patient-specific customization. Additionally, the industry is seeing growth in outpatient surgery settings, modular implant systems, and advanced biomaterials designed to reduce wear and extend implant lifespan.
- •Robotic-assisted knee replacement is accelerating adoption, with surgeons increasingly utilizing systems for enhanced accuracy, reduced variability, and faster patient recovery
- •Personalized and 3D-printed implants are gaining clinical acceptance, enabling patient-specific surgical planning based on individual anatomy
- •Shift toward outpatient and ambulatory surgery centers is reducing healthcare costs and expanding access, particularly in markets with aging infrastructure
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.